Eight biopharmaceutical companies went public in the US during May with mixed results – including mid-month initial public offerings from Applied Therapeutics Inc., Bicycle Therapeutics Ltd. and IDEAYA Biosciences Inc. – and eight more companies indicated their IPO aspirations in recent weeks.
Five drug developers launched first-time offerings on 7 and 8 May, followed by Applied Therapeutics, Bicycle and IDEAYA. The offerings bring the year's total to 21 biopharma IPOs in the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?